Wei Li
Harbin Medical University(CN)Kunming Institute of Zoology(CN)Third Affiliated Hospital of Harbin Medical University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Immune Cell Function and Interaction, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Hepatitis C virus research
Most-Cited Works
- → Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study(2023)612 cited
- → Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network(2017)452 cited
- → Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4 + T Cells(1996)426 cited
- → VEGF Prevents Apoptosis of Human Microvascular Endothelial Cells via Opposing Effects on MAPK/ERK and SAPK/JNK Signaling(1999)380 cited
- → Phenotypic and Genotypic Characterization of Carbapenem-resistantEnterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012–2016)(2018)352 cited
- → STAT3 Contributes to the Mitogenic Response of Hepatocytes during Liver Regeneration(2002)311 cited